Primary Category:
Treatment Protocols
Disease Category:
Adjuvant Breast, Breast
Status:
Closed
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e^3 Breast Cancer Study-Evaluating Everolimus with Endocrine Therapy
NCT#01674140
S1207 is closed to accrual effective May 1, 2019.
Eligible for screening study DCP 001